Antifungal Susceptibility Testing of Candida Isolates from the Candida Surveillance Study

Lyon, G. Marshall; Karatela, Sulaiman; Sunay, Susan; Adiri, Yaffa

doi:10.1128/jcm.02363-09

Cited by 111Antifungal resistance and susceptibilityYeasts and Rust Fungi StudiesFungal Infections and Studies

Antifungal Susceptibility Testing of Candida Isolates from the Candida Surveillance Study

Open access

Lyon, G. Marshall, Karatela, Sulaiman, Sunay, Susan, Adiri, Yaffa·2010·Journal of Clinical Microbiology

DOI 10.1128/jcm.02363-09PMC PMC2849617

Open this paper in CoChat — free account

Abstract

Candida species are a common cause of nosocomial bloodstream infections. Recent surveillance has shown an increase in the relative proportion of infections caused by Candida glabrata, which has reduced susceptibility to fluconazole. We undertook sentinel surveillance with antifungal susceptibility testing to monitor the trends in the proportions of various Candida species causing invasive disease. Forty-one institutions participated in the Candida Surveillance Study. All isolates were submitted to a central laboratory for identification and susceptibility testing. Susceptibility testing was performed in compliance with CLSI guidelines using a custom, broth dilution, microtiter system. There were 5,900 isolates submitted for identification and antifungal susceptibility testing. The distribution of species was as follows: C. albicans, 2,567 (43.5%) isolates; C. glabrata, 1,464 (24.8%) isolates; C. parapsilosis, 1,048 (17.8%) isolates; C. tropicalis, 527 (8.9%) isolates; C. krusei, 109 (1.9%) isolates; C. lusitaniae, 76 (1.3%) isolates; and other Candida species, 109 (1.9%) isolates. Resistance to fluconazole occurred in 1.2% of C. albicans isolates, 5.9% of C. glabrata isolates, 0.3% of C. parapsilosis isolates, and 0.4% of C. tropicalis isolates. Resistance to fluconazole was highly predictive of resistance to voriconazole. Resistance to echinocandins was rarely found, occurring in only 0.2% of all isolates. The rate of fluconazole susceptibility increased significantly from 87.5% in 2005 to 97.4% in 2007. The proportion of cases of disease caused by various Candida species did not change appreciably between 2004 and 2007, and the rate of antifungal susceptibility was high.

Integrity signals

Registry

Crossref · 10.1128/jcm.02363-09

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

With respect to CLSI clinical breakpoints, fluconazole resistance, defined as MIC values ≥8 mg/L for C. albicans, has been reported overall to be as high as 3.5%.
“With respect to CLSI clinical breakpoints, fluconazole resistance, defined as MIC values ≥8 mg/L for C. albicans, has been reported overall to be as high as 3.5%.43–48”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungusCandida albicans (2020) · cites this paper as [44]

Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,045 · see citing works
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · see citing works
Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052 · see citing works
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880 · see citing works
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755 · see citing works
Secular Trend of Hospital‐Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989–1999
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660 · see citing works
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Parczewska, O. K., Posaconazol, przeciwgrzybicze, L., Anidulafungina, Micafungina, & wrażliwość, O. (2009) · Cited by 656 · see citing works
Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program
Hajjeh, R. A., Sofair, A. N., Harrison, L. H., Lyon, G. M., Arthington-Skaggs, B. A., Mirza, S. A., Phelan, M., Morgan, J., Lee-Yang, W., Ciblak, M. A., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1519-1527.2004 · Cited by 649 · see citing works
Self-citation
Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
Pappas, P. G., Rotstein, C. M. F., Betts, R. F., Nucci, M., Talwar, D., De Waele, J. J., Vazquez, J. A., Dupont, B. F., Horn, D. L., Ostrosky-Zeichner, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/520980 · Cited by 638 · see citing works
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance.
Kao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457 · see citing works
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida
Pfaller, M. A., & Diekema, D. J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.t01-1-00844.x · Cited by 422 · see citing works
In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance
Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01901-07 · Cited by 389 · see citing works
Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study
Diekema, D. J., Messer, S. A., Brueggemann, A. B., Coffman, S. L., Doern, G. V., Herwaldt, L. A., & Pfaller, M. A. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1298-1302.2002 · Cited by 385 · see citing works
Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998
Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S., Hollis, R. J., & The SENTRY Participant Group (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.747-751.2000 · Cited by 378 · see citing works
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Hu, B., Dzierzanowska, D., Климко, Н. Н., Letscher‐Bru, V., Lisalová, M., Muehlethaler, K., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01747-08 · Cited by 370 · see citing works
Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing
Pfaller, M. A., Diekema, D. J., & Sheehan, D. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.435-447.2006 · Cited by 298 · see citing works
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Meis, J. F. G. M., Gould, I. M., Fu, W., Colombo, A. L., & Rodríguez-Noriega, E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00409-07 · Cited by 287 · see citing works
Systemic Antifungal Agents
Albengres, E., Lou, L., & Tillement, J. P. (1998) · Drug Safety · doi:10.2165/00002018-199818020-00001 · Cited by 279 · see citing works
Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints
Pfaller, M. A., Diekema, D. J., Rex, J. H., Espinel-Ingroff, A., Johnson, E. M., Andes, D., Chaturvedi, V., Ghannoum, M. A., Odds, F. C., Rinaldi, M. G., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.819-826.2006 · Cited by 258 · see citing works
Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints
Pfaller, M. A., Diekema, D. J., Ostrosky-Zeichner, L., Rex, J. H., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Ghannoum, M. A., Knapp, C. C., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00566-08 · Cited by 250 · see citing works
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp
Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., Jones, R. N., Turnidge, J. D., & Diekema, D. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01590-09 · Cited by 154 · see citing works
In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of RareCandidaSpecies as Determined by CLSI Broth Microdilution Methods
Diekema, D. J., Messer, S. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Tendolkar, S., & Pfaller, M. A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00942-09 · Cited by 125 · see citing works
Voriconazole Salvage Treatment of Invasive Candidiasis
Ostrosky‐Zeichner, L., Lashof, A. M. L. O., Kullberg, B. J., & Rex, J. H. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1014-3 · Cited by 125 · see citing works
Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals
Blignaut, E., Messer, S. A., Hollis, R. J., & Pfaller, M. A. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00440-6 · Cited by 65 · see citing works

Flagged first, then by citations

Sorted by citations

Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.
Lockhart, S. R., Iqbal, N., Cleveland, A. A., Farley, M. M., Harrison, L. H., Bolden, C. B., Baughman, W., Stein, B., Hollick, R., Park, B. J., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01283-12 · Cited by 299 · see citing works
Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance
Pham, C. D., Iqbal, N., Bolden, C. B., Kuykendall, R. J., Harrison, L. H., Farley, M. M., Schaffner, W., Beldavs, Z. G., Chiller, T. M., Park, B. J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03255-14 · Cited by 231 · see citing works
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Bitew, A., & Abebaw, Y. (2018) · BMC Women s Health · doi:10.1186/s12905-018-0607-z · Cited by 212 · see citing works
Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)
Montagna, M. T., Caggiano, G., Lovero, G., Giglio, O. D., Coretti, C., Cuna, T., Iatta, R., Giglio, M., Dalfino, L., Bruno, F., et al. (2013) · Infection · doi:10.1007/s15010-013-0432-0 · Cited by 188 · see citing works
Synergistic Effect of the Flavonoid Catechin, Quercetin, or Epigallocatechin Gallate with Fluconazole Induces Apoptosis in Candida tropicalis Resistant to Fluconazole
da Silva, C. R., Neto, J. B. D. A., Campos, R. D. S., Figueiredo, N. S., Sampaio, L. S., Magalhães, H. I. F., Cavalcanti, B. C., Macêdo, D. S., de Andrade, G. M., Lima, I. S. P., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00651-13 · Cited by 130 · see citing works
Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland
Orasch, C., Marchetti, O., Garbino, J., Schrenzel, J., Zimmerli, S., Mühlethaler, K., Pfyffer, G. E., Ruef, C., Fehr, J. S., Zbinden, R., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12440 · Cited by 122 · see citing works
Invasive candidiasis species distribution and trends, United States, 2009-2017
Ricotta, E. E., Lai, Y. L., Babiker, A., Strich, J. R., Kadri, S. S., Lionakis, M. S., Prevots, D. R., & Adjemian, J. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa502 · Cited by 114 · see citing works
Effect of pH on In Vitro Susceptibility of Candida glabrata and Candida albicans to 11 Antifungal Agents and Implications for Clinical Use
Danby, C. S., Boikov, D. A., Rautemaa‐Richardson, R., & Sobel, J. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05025-11 · Cited by 114 · see citing works
The Consequences of Our Changing Environment on Life Threatening and Debilitating Fungal Diseases in Humans
van Rhijn, N., & Bromley, M. (2021) · Journal of Fungi · doi:10.3390/jof7050367 · Cited by 118 · see citing works
In vitro antifungal activity of the flavonoid baicalein against Candida species
Serpa, R., de França, E. J. G., Furlaneto-Maia, L., Andrade, C. G. T. J., Diniz, A., & Furlaneto, M. C. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.047852-0 · Cited by 110 · see citing works
Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungusCandida albicans
Nishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102 · see citing works
Current Epidemiology of Candida Infection
Lockhart, S. R. (2014) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2014.08.001 · Cited by 101 · see citing works
Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites
Durnaś, B., Wnorowska, U., Pogoda, K., Deptuła, P., Wątek, M., Piktel, E., Głuszek, S., Gu, X., Savage, P. B., Niemirowicz, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157242 · Cited by 82 · see citing works
Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia
Seyoum, E., Bitew, A., & Mihret, A. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4883-5 · Cited by 87 · see citing works
Optimizing antifungal choice and administration
Andes, D. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761135 · Cited by 63 · see citing works
General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation
Corzo-León, D., Peacock, M., Rodríguez‐Zulueta, P., Salazar-Tamayo, G., & MacCallum, D. M. (2020) · Medical Mycology · doi:10.1093/mmy/myaa098 · Cited by 58 · see citing works
Mechanisms involved in the triggering of neutrophil extracellular traps (NETs) by Candida glabrata during planktonic and biofilm growth
Johnson, C. J., Kernien, J. F., Hoyer, A. R., & Nett, J. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-13588-6 · Cited by 58 · see citing works
Quantitative and Qualitative Analysis of the Antifungal Activity of Allicin Alone and in Combination with Antifungal Drugs
Kim, Y., Kim, K. S., Han, I., Kim, M., Jung, M. H., & Park, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038242 · Cited by 55 · see citing works
Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance
Papp, C., Kocsis, K., Tóth, R., Bodai, L., Willis, J. R., Księżopolska, E., Lozoya‐Pérez, N. E., Vágvölgyi, C., Montes, H. M. M., Gabaldón, T., et al. (2018) · mSphere · doi:10.1128/msphere.00547-18 · Cited by 51 · see citing works
Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey
Kutlu, M., Kutlu, S. S., Çavuş, S. A., Öztürk, Ş. B., Tasbakan, M. I., Özhak, B., Kaya, O., Kutsoylu, O. Ö. E., Akar, Ş. Ş., Turhan, Ö., et al. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04394-0 · Cited by 48 · see citing works
Fungal Infections of the Spine
Ganesh, D., Gottlieb, J., Chan, S. F., Martínez, O., & Eismont, F. J. (2015) · Spine · doi:10.1097/brs.0000000000000903 · Cited by 46 · see citing works
SUSCEPTIBILITY OF Candida spp. ISOLATED FROM BLOOD CULTURES AS EVALUATED USING THE M27-A3 AND NEW M27-S4 APPROVED BREAKPOINTS
dos Santos, E. R., Forno, C. F. D., Liscano, M. G. H., Kubiça, T. F., Venturini, T. P., Chassot, F., Santurio, J. M., & Alves, S. H. (2014) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652014000600004 · Cited by 42 · see citing works
Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period
Furlaneto, M. C., Rota, J. F., Quesada, R. M. B., Furlaneto-Maia, L., Rodrigues, R., Oda, S., de Oliveira, M. T., Serpa, R., & de França, E. J. G. (2011) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822011000500013 · Cited by 44 · see citing works
Species Distribution, Antifungal Susceptibility, and Molecular Epidemiology of Candida Species Causing Candidemia in a Tertiary Care Hospital in Bangkok, Thailand
Boonsilp, S., Homkaew, A., Phumisantiphong, U., Nutalai, D., & Wongsuk, T. (2021) · Journal of Fungi · doi:10.3390/jof7070577 · Cited by 42 · see citing works
Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran
Razzaghi‐Abyaneh, M., Sadeghi, G., Zeinali, E., Alirezaee, M., Shams‐Ghahfarokhi, M., Amani, A., Mirahmadi, R., & Tolouei, R. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2014.01.004 · Cited by 39 · see citing works
Candida Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital
Alkharashi, N., AlJohani, S. M., Layqah, L. A., Masuadi, E., Baharoon, W., Al-Jahdali, H. H., & Baharoon, S. A. (2019) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2019/2015692 · Cited by 40 · see citing works
Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients
Zhang, W., Song, X., Wu, H., & Zheng, R. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05238-6 · Cited by 38 · see citing works
Epidemiology of candidemia and impact of infectious disease consultation on survival and care
Mohr, A., Simon, M., Joha, T., Hanses, F., Salzberger, B., & Hitzenbichler, F. (2020) · Infection · doi:10.1007/s15010-020-01393-9 · Cited by 36 · see citing works
Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility
Khairat, S. M., Sayed, A. M., Nabih, M., Soliman, N. S., & Hassan, Y. M. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s196972 · Cited by 35 · see citing works
The yeast, the antifungal, and the wardrobe: a journey into antifungal resistance mechanisms of Candida tropicalis
de Oliveira, J. S., Pereira, V. S., Castelo‐Branco, D. D. S. C. M., Cordeiro, R. D. A., Sidrim, J. J. C., Brilhante, R. S. N., & Rocha, M. F. G. (2020) · Canadian Journal of Microbiology · doi:10.1139/cjm-2019-0531 · Cited by 38 · see citing works
Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011
Li, F., Wu, L., Cao, B., Zhang, Y., Li, X., & Liu, Y. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-353 · Cited by 35 · see citing works
Ten-year review of invasive Candida infections in a tertiary care center in Saudi Arabia
Omrani, A. S., Makkawy, E. A., Baig, K., Baredhwan, A. A., Almuthree, S. A., Elkhizzi, N. A., & Albarrak, A. M. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.6005 · Cited by 33 · see citing works
Antifungal susceptibility pattern of Candida species isolated from pregnant women
Ali, M., Edrees, W. H., Al-Shehari, W. A., Gao, X., Al-Hammadi, S., Qasem, E. A., Chaulagain, R. P., & Lal, N. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1434677 · Cited by 34 · see citing works
Rapid Identification of Candida Species from Positive Blood Cultures by Use of the FilmArray Blood Culture Identification Panel
Simor, A. E., Porter, V. R., Mubareka, S., Chouinard, M., Katz, K. C., Vermeiren, C. L., Fattouh, R., Matukas, L. M., Tadros, M., Mazzulli, T., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01387-18 · Cited by 27 · see citing works
Clinical Characteristics of Turkish Women with Candida krusei Vaginitis and Antifungal Susceptibility of the C. krusei Isolates
Güzel, A. B., Aydın, M., Meral, M., Kalkancı, A., & Ilkit, M. (2013) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2013/698736 · Cited by 27 · see citing works
Echinocandins: Addressing outstanding questions surrounding treatment of invasive fungal infections
Holt, S. L., & Drew, R. H. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100456 · Cited by 26 · see citing works
Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections
Puig‐Asensio, M., Fernández‐Ruiz, M., Aguado, J. M., Merino, P., Lora, D., Guinea, J., Martín‐Dávila, P., Cuenca‐Estrella, M., & Almirante, B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00195-16 · Cited by 26 · see citing works
Synthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity
Borowiecki, P., Wińska, P., Bretner, M., Gizińska, M., Koronkiewicz, M., & Staniszewska, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.077 · Cited by 25 · see citing works
Evaluation of Antifungal Susceptibility Testing with Microdilution and Etest Methods of Candida Blood Isolates
Metin, D. Y., Polat, S. H., Şamlıoğlu, P., Doganay-Oflazoglu, B., İnci, R., & Tümbay, E. (2011) · Mycopathologia · doi:10.1007/s11046-011-9413-y · Cited by 22 · see citing works
Species distribution and antifungal susceptibility profile of Candida isolates from blood and other normally sterile foci from pediatric ICU patients in Tehran, Iran
Mirhendi, H., Charsizadeh, A., Eshaghi, H., Nikmanesh, B., & Arendrup, M. C. (2019) · Medical Mycology · doi:10.1093/mmy/myz047 · Cited by 21 · see citing works
Antifungal Susceptibility Profile of Candida Albicans Isolated from Vulvovaginal Candidiasis in Xinjiang Province of China
Yan, L., Wang, X.-D., Seyedmousavi, S., Yuan, J.-N., Abulize, P., Pan, W., Yu, N., Yang, Y., Hu, H.-Q., Liao, W., et al. (2019) · Mycopathologia · doi:10.1007/s11046-018-0305-2 · Cited by 20 · see citing works
Probiotic yeastSaccharomyces boulardii(nom. nud.) modulates adhesive properties ofCandida glabrata
Tomičić, Z., Zupan, J., Matos, T., & Raspor, P. (2016) · Medical Mycology · doi:10.1093/mmy/myw026 · Cited by 19 · see citing works
Application of Novel Short Tandem Repeat Typing for Wickerhamomyces anomalus Reveals Simultaneous Outbreaks within a Single Hospital
Spruijtenburg, B., Rudramurthy, S. M., Meijer, E. F. J., van Haren, M. H. I., Kaur, H., Chakrabarti, A., Meis, J. F. G. M., & de Groot, T. (2023) · Microorganisms · doi:10.3390/microorganisms11061525 · Cited by 19 · see citing works
A Predominance of Clade 17 Candida albicans Isolated From Hemocultures in a Tertiary Care Hospital in Thailand
Pham, L. T. T., Pharkjaksu, S., Chongtrakool, P., Suwannakarn, K., & Ngamskulrungroj, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01194 · Cited by 21 · see citing works
A multicenter retrospective analysis of the antifungal susceptibility patterns of Candida species and the predictive factors of mortality in South Korean patients with candidemia
Jung, I. Y., Jeong, S. J., Kim, Y. K., Kim, H. Y., Song, Y. G., Kim, J. M., & Choi, J. Y. (2020) · Medicine · doi:10.1097/md.0000000000019494 · Cited by 15 · see citing works
In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen
Amirrajab, N., Badali, H., Didehdar, M., Afsarian, M. H., Mohammadi, R., Lotfi, N., & Shokohi, T. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.36638 · Cited by 14 · see citing works
Candidemia in patients with prolonged fever in Kashan, Iran
Rezai, R., Momen–Heravi, M., Erami, M., & Nazeri, M. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.3.20 · Cited by 13 · see citing works
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole
Rudramurthy, S. M., Jatana, M., Singh, R., & Chakrabarti, A. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02197.x · Cited by 13 · see citing works
Antifungal and antibiofilm effects of probiotic Lactobacillus salivarius, zinc nanoparticles, and zinc nanocomposites against Candida albicans from Nile tilapia (Oreochromis niloticus), water and humans
El-Gazzar, N. S., Elez, R. M. M. A., Attia, A. S. A., Abdel‐Warith, A. A., Darwish, M. M., Younis, E. M., El-Tahlawi, R., Ibraheem, K. I. M., Davies, S. J., & Elsohaby, I. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1358270 · Cited by 11 · see citing works
Candida lusitaniae MICs to the echinocandins are elevated but FKS -mediated resistance is rare
Lockhart, S. R., Pham, C. D., Kuykendall, R. J., Bolden, C. B., & Cleveland, A. A. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.08.012 · Cited by 11 · see citing works
Azole Antifungal Resistance in Candida albicans and Candida glabrata Isolated from Vulvovaginal Candidiasis Patients
Deravi, N., Fathi, M., Tabatabaeifar, S. N., Pooransari, P., Ahmadi, B., Shokoohi, G., Yaghoobpoor, S., Vakili, K. G., Lotfali, E., & Ansari, S. (2021) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.106360 · Cited by 11 · see citing works
Antifungal Susceptibility Pattern of Candida glabrata from a Referral Center and Reference Laboratory: 2012–2022
Chesdachai, S., Yetmar, Z. A., Ranganath, N., Everson, J. J., Wengenack, N. L., & Saleh, O. A. (2023) · Journal of Fungi · doi:10.3390/jof9080821 · Cited by 11 · see citing works
Antifungal Susceptibility Testing of Candida Isolates from the Candida Surveillance Study
Khardori, N. M. (2010) · Yearbook of Medicine · doi:10.1016/s0084-3873(10)79682-6 · Cited by 10 · see citing works
In Vitro Activity of Caspofungin Against Fluconazole-Resistant Candida Species Isolated From Clinical Samples in Iran
Abad, H. S. E., Zaini, F., Kordbacheh, P., Mahmoudi, M., Safara, M., & Mortezaee, V. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.18353v2 · Cited by 10 · see citing works
Antimicrobial Activity of the Anthocyanins Isolated from Purple Field Corn (Zea mays L.) Cob against Candida spp
Suket, N., Srisook, E., & Hrimpeng, K. (2014) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-09424044 · Cited by 10 · see citing works
Global prevalence and trends of fluconazole resistance in non-albicans Candida species: a systematic review and meta-analysis
Li, X., Sholeh, M., Moghadam, M. A., Ostadrahimi, M., & Hosseini, S. S. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-12653-8 · Cited by 10 · see citing works
Profiling of potential pulmonary fungal pathogens and the prevalence of the association between pulmonary tuberculosis and potential fungal pathogens in presumptive tuberculosis patients referred to Saint Peter’s Specialized Tuberculosis Referral Hospital, Addis Ababa, Ethiopia
Bitew, A., & Kejela, S. B. (2021) · SAGE Open Medicine · doi:10.1177/20503121211056163 · Cited by 8 · see citing works
Genetic diversity of theHwp1gene andHIS3, EF3, CDC3microsatellites and antifungal susceptibility profiles ofCandida albicansisolates from Yaoundé HIV-infected patients
Ngouana, T. K., Drakulovski, P., Krasteva, D., Toghueo, R. M. K., Kouanfack, C., Reynes, J., Delaporte, É., Boyom, F. F., Mallié, M., & Bertout, S. (2016) · Medical Mycology · doi:10.1093/mmy/myw108 · Cited by 8 · see citing works
Candida Glabrata Perinephric Abscess
Balkan, İ. İ., Savas, A., Gedük, A., Yemişen, M., Mete, B., & Özaras, R. (2011) · Eurasian Journal of Medicine · doi:10.5152/eajm.2011.14 · Cited by 8 · see citing works
Impact of Biofilm Formation by Vaginal Candida albicans and Candida glabrata Isolates and Their Antifungal Resistance: A Comprehensive Study in Ecuadorian Women
Cedeño-Pinargote, A. C., Jara-Medina, N. R., Pineda-Cabrera, C. C., Cueva, D. F., Erazo-Garcia, M. P., Tejera, E., & Machado, A. (2025) · Journal of Fungi · doi:10.3390/jof11090620 · Cited by 10 · see citing works
Species Identification And Antifungal Susceptibility Pattern Of Candida Isolates From Oropharyngeal Lesions Of HIV Infected Patients.
Deorukhkar, S. C., Katiyar, R., & Saini, S. (2012) · National journal of integrated research in medicine · Cited by 7 · see citing works
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Biçmen, C., Dereli, M. D., GÜLAT, S., Gündüz, A. T., & Tuksavul, F. (2012) · PubMed · Cited by 7 · see citing works
Species distribution and antifungal susceptibility pattern of candida isolates from pregnant women in a tertiary hospital in Nigeria
Efunshile, A., Oduyebo, O. O., Osuagwu, C. S., & Koenig, B. F. (2016) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v17i3.5 · Cited by 6 · see citing works
Antifungal Activity of Polyscias scutellaria Fosberg Leaves Against Candida albicans
Putri, N. M., Putri, J. R., Elya, B., & Adawıyah, R. (2020) · Pharmaceutical Sciences and Research · doi:10.7454/psr.v7i3.1026 · Cited by 7 · see citing works
Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern
Baniasadi, A. K., Mousavi, S. A. A., Sharifi, I., Bamorovat, M., Salari, S., Ahmadi, A., Amanizadeh, A., & Afshari, S. A. K. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15442 · Cited by 6 · see citing works
Evaluación de las tarjetas AST-YSO1 del sistema Vitek 2 para determinar la sensibilidad a antifúngicos de levaduras del género Candida
Ochiuzzi, M. E., Arechavala, A. I., Guelfand, L. I., Maldonado, I., & Soloaga, R. N. (2014) · Revista Argentina de Microbiología · doi:10.1016/s0325-7541(14)70058-6 · Cited by 6 · see citing works
Prevalence of Virulence Genes and Antifungal Resistance in Candida albicans Isolated from Raw Goat Milk
Soliman, M. M. H., Kandil, M. M., Elnemr, S., & Abuelnaga, A. S. M. (2020) · World s Veterinary Journal · doi:10.54203/scil.2020.wvj81 · Cited by 6 · see citing works
In Vitro Susceptibilities of Non-albicans Candida Species to Echinocandins, Azoles, and Amphotericin B in Tokat, Turkey
Yenişehirli, G., Özveren, G., Yenişehirli, A., & Bulut, Y. (2018) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.59404 · Cited by 5 · see citing works
Candidiasis and Less Common Yeast Genera
Reiss, E., Shadomy, H. J., & Lyon, G. M. (2011) · doi:10.1002/9781118101773.ch11 · Cited by 5 · see citing works
Self-citation
Chemical composition, antimicrobial, antioxidant, and toxicity of essential oils as food preservatives
Dadbin, M., Soltanpour, M., Khodaie, L., & Islambulchilar, M. (2025) · Journal of Research in Pharmacy · doi:10.12991/jrespharm.1653671 · Cited by 4 · see citing works
Invasive candidosis: contrasting the perceptions of infectious disease physicians and intensive care physicians
Schultz, V., Colombo, A. L., & Pasqualotto, A. C. (2013) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0057-2013 · Cited by 4 · see citing works
Proteomic Analysis of Intracellular and Membrane Proteins From Voriconazole-Resistant Candida glabrata
Yoo, J. I., Kim, H. S., Choi, C. W., Yoo, J. S., Yu, J. Y., & Lee, Y. S. (2013) · Osong Public Health and Research Perspectives · doi:10.1016/j.phrp.2013.10.001 · Cited by 4 · see citing works
CaMad2 Promotes Multiple Aspects of Genome Stability Beyond Its Direct Function in Chromosome Segregation
Vossen, M. L., Alhosawi, H. M., Aney, K. J., & Burrack, L. S. (2019) · Genes · doi:10.3390/genes10121013 · Cited by 4 · see citing works
Changing Trends of Candida Species and Antifungal Susceptibility Profile of Candida Bloodstream Isolates: A 5-Year Retrospective Survey
Yardımcı, A. C., & Arman, D. (2022) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.120801 · Cited by 4 · see citing works
Arteriovenous graft infection caused by Candida glabrata: A case report and literature review
Huang, H., Lin, C., Chang, Y.-T., Chen, Y., Wu, W.-T., & Lu, P. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.05.005 · Cited by 4 · see citing works
Prevalence and in vitro Antifungal Susceptibility Pattern of Candida species in a Tertiary Care Hospital, Rawalpindi, Pakistan
Aslam, A., Akhtar, N., Hasan, F., & Shah, A. A. (2015) · Pakistan Journal of Zoology · Cited by 4 · see citing works
Antifungal susceptibility and virulence profile of candida isolates from abnormal vaginal discharge of women from southern India
Arumugam, G., Prabhusaran, N., Pramila, M., Balasubramanian, S., Archunan, P. A., Archunan, G., & Rajaram, R. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.09.021 · Cited by 3 · see citing works
Candidiasis
Schuster, J. E., & Fisher, B. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64198-2.00035-x · Cited by 3 · see citing works
Multicenter Identification and Antifungal Susceptibility Patterns of Candida Species Isolated from Clinical Samples
Badiee, P., Badali, H., Diba, K., Jafarian, H., Mohammadi, R., Mirhendi, H., & Najafzadeh, M. J. (2017) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.56117 · Cited by 3 · see citing works
A pseudo-outbreak of echinocandin-resistant Candida glabrata: The unreliability of caspofungin testing in predicting echinocandin susceptibility
Shabi, Y., Russell-Tattrie, A., Bharat, A., Haldane, D. J. M., & Patriquin, G. (2021) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2020-0023 · Cited by 2 · see citing works
Isolation of Hemolymph-derived Antifungal Product from Marine Crab Dromia dehaani
Ravichandran, S., Alagumuthu, M., Suresh, J., & Vadlaganti, V. S. (2025) · Current Analytical Chemistry · doi:10.2174/0115734110343339250120103702 · Cited by 2 · see citing works
Comparative In Vitro Activities of Fluconazole, Voriconazole, and MXP-4509 Against Romanian Blood Yeast Isolates
Mareș, M., Năstasă, V., Ramona, F. M., Doroftei, B., & Ştefanache, A. (2011) · Mycopathologia · doi:10.1007/s11046-011-9455-1 · Cited by 2 · see citing works
Susceptibility to amphotericin B of Candida spp. strains isolated in Ceará, Northeastern Brazil
da Silva, C. R., Magalhães, H. I. F., de Moraes, M. O., & Júnior, H. V. N. (2013) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-1060-2013 · Cited by 2 · see citing works
The first reported case of colonic infection caused by Candida glabrata
Jiménez‐Rosales, R., Carrasco, C., & Hinojosa, M. O. (2019) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2019.6057/2018 · Cited by 2 · see citing works
Candidemia in a Pediatric Population: A 10-year Indian Study
Joshi, S., Venkatesh, B. M., Adhikary, R., & Aravinda, A. (2021) · Pediatric Infectious Disease · doi:10.5005/jp-journals-10081-1255 · Cited by 2 · see citing works
One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?
Turan, D., & Aksaray, S. (2022) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20229709 · Cited by 3 · see citing works
Antifungal therapy: current concepts and evidence-based management
Perfect, J. R., & Andes, D. R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761136 · Cited by 1 · see citing works
In Vitro Antidrug Susceptibility Testing of Candida Species Isolated from Aseptic Body Fluids
Xiang, G.-S., Zeng, L., Zhang, J., Ying, Y., Deng, X.-R., Hu, X., Yan, Y., Yu, K., Zou, W.-W., & Huang, X. (2018) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.55547 · Cited by 1 · see citing works
Mating genotypes and susceptibility profiles of clinical isolates of Candida glabrata from Turkey
Kaplan, E., Aktaş, D., Önder, Ş., Metin, B., Döğen, A., Öz, Y., & İlkit, M. (2019) · Mycoses · doi:10.1111/myc.12945 · Cited by 1 · see citing works
in vitro Activity of Seven Antifungals against Different Clinical Candida Species
Gharghani, M., Rezaei‐Matehkolaei, A., Shokoohi, G., Taghavi, J., & Nouripour‐Sisakht, S. (2021) · Journal of Clinical Care and Skills · doi:10.52547/jccs.2.4.195 · Cited by 1 · see citing works
Identification, Prevalence and Susceptibility Profile of Candida Isolates at the Pasteur Institute in Côte D'ivoire from 2017 to 2019
Bonouman Ira, A. V., M'boh, R., Roger, F., Krasteva, D., Bellet, V., Koffi, D., Noëll, J., Pottier, C., Drakulovski, P., Menan, H. I. E., et al. (2023) · African Journal of Biology and Medical Research · doi:10.52589/ajbmr-3ffy5hwh · Cited by 1 · see citing works
Identification, Prevalence and Susceptibility Profile of Candida Isolates at the Pasteur Institute in Côte D'ivoire From 2017 to 2019Preprint
Ira, V. B., M'boh, R., Roger, F., Krasteva, D., Koffi, D., Noëll, J., Pottier, C., Bellet, V., Drakulvoski, P., Menan, H. I. E., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1882513/v1 · Cited by 1 · see citing works
Antifungal Susceptibility Pattern of Candida species Isolated from Pregnant Women in Hajjah Governorate, YemenPreprint
Gao, X., Ali, M., Edrees, W. H., Al-Shehari, W. A., Chaulagain, R. P., Lal, N., Al-Hammadi, S., & Qasem, E. A. (2023) · Research Square · doi:10.21203/rs.3.rs-3318102/v3 · Cited by 1 · see citing works
Molecular typing of Candida albicans isolates from Lebanese hospitals in correlation to: Phenotypic identification, epidemiology, antifungal resistance profile, and biofilm formation. (c2013)
Bitar, I. (2013) · doi:10.26756/th.2013.17
Review Optimizing antifungal choice and administration
Andes, D. R. (2013)
Candidaemia or Candidasis: Controversy of Staphylococcus Sexually Transmitted Infection?
Ogunshe, A. O. (2024) · African Journal of Biomedical Research · doi:10.53555/ajbr.v19i1.531
Title: Role of initial antifungal therapy in the outcome of Candida glabrata bloodstream
Puig‐Asensio, M., Fernández‐Ruiz, M., Merino, P., & Lora, D. (2016)
An Investigation into Clinically Relevant Determinants of Azole Resistance in Candida albicans
Nishimoto, A. T. (2019) · doi:10.21007/etd.cghs.2019.0486
Antibiogram of Candida Species using Different Susceptibility Testing Techniques: A Systematic Review
Sule, H., Kumurya, A. S., & Ibrahim, A. (2020) · UMYU Journal of Microbiology Research (UJMR) · doi:10.47430/ujmr.2051.006
Fungemias en pacientes con neoplasias hematológicas en Instituciones de Bogotá
Espíndola, V., & Alejandra, L. (2021)

Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in
(2016)
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States
Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N., Doern, G. V., Brandt, M. E., & Hajjeh, R. A. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00160-6 · Cited by 216 · see citing works
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.
Lockhart, S. R., Iqbal, N., Cleveland, A. A., Farley, M. M., Harrison, L. H., Bolden, C. B., Baughman, W., Stein, B., Hollick, R., Park, B. J., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01283-12 · Cited by 299 · see citing works
Susceptibilidad a azoles y anfotericina B de aislados de Candida spp: Experiencia de una red de salud universitaria,entre 2004 y 2010
Lorena Porte, T., León, P., Gárate, C., Guzmán, A. M., Labarca, J. A., & García, P. (2012) · Revista chilena de infectología · doi:10.4067/s0716-10182012000200005 · Cited by 11 · see citing works
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825 · see citing works

Authors: Lyon, G. M., Karatela, S., Sunay, S., & Adiri, Y.
Affiliations: Emory University (US)
Venue: Journal of Clinical Microbiology
Publisher: American Society for Microbiology
Published: 2010-04
Volume: 48
Issue: 4
Pages: 1270-1275
ISSN: 0095-1137 (ISSN-L)
1098-660X
DOI: 10.1128/jcm.02363-09
PMC: PMC2849617
OpenAlex: W2117828731
Cited by: 111
References: 24
Citations by year: 2026: 2 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 12 · 2019: 10 · 2018: 6 · 2017: 2 · 2016: 8 · 2015: 5 · 2014: 7 · 2013: 13 · 2012: 7
FWCI: 5.58
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Clinical Microbiology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Veterans Affairs
Cleveland Clinic
University of Washington
University of Pittsburgh
University of Louisville
University of Oklahoma
University of Rochester
Hennepin County Medical Center
Ochsner Health
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords: Candida, antifungal susceptibility, Candida glabrata, fluconazole resistance, voriconazole resistance, echinocandin resistance, Candida albicans, Candida parapsilosis, Candida tropicalis, Candida krusei, Candida lusitaniae, invasive candidiasis, nosocomial bloodstream infection, sentinel surveillance, Candida species distribution
MeSH terms: Antifungal Agents, Candida, Candidiasis, Cross Infection, Humans, Microbial Sensitivity Tests, Pyrimidines, Triazoles, Fluconazole, Echinocandins, Voriconazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antifungal Susceptibility Testing of Candida Isolates from the Candida Surveillance Study

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks